In experiments designed to detect new mutations affecting hemoglobin, we irradiated the male or female parent in reciprocal crosses of two mouse strains that differ in alleles at the hemoglobin (Hba, Hbb) (6) (7) (8) (9) , and these are codominantly expressed in heterozygotes. Crosses were made
indicates the need, in similar experiments, to follow F1 screening with thorough cytogenetic analysis. The variants in which there is nonexpression of the a chain may be'the result of small deficiencies or of faults in transcription or translation. Mutation rates based on these three variants are not out of line with earlier specific-locus results, although confidence limits are still wide.
The specific-locus method has been used for years at this laboratory in the course of experiments designed to determine the effects of biological and physical variables on the frequency and nature of induced mutations (1, 2) . For several of the loci used in such experiments, the pathways from gene to character are at least partially known; and mutations involving these loci have been analyzed by complementation studies and other means to determine their genetic nature (3, 4) .
Specific-locus work has now been extended to two additional loci which control a product that is better defined, chemically, than any other character of the mouse, namely, hemoglobin. Our objectives are as follows: (a) to derive, from analysis of the mutant product, additional clues as to the nature of the mutations; (b) to determine, therefrom, mutation rates for clearly defined biochemical variants; and (c) to discover new variants of intrinsic interest at the hemoglobin loci and possibly at other loci affecting blood characters.
The method has been successful, and several hemoglobin mutants have been recovered, including one that turned out to be a tandem duplication, the first reported in the mouse (5 Irradiation and Subsequent Breeding. Either the male or the female parent was irradiated in both of the reciprocal crosses (Table 1) . Acute x-irradiation was used in each case (87-91 R/min; 250 kV peak; 30 mA; inherent filtration, 3 mm aluminum; Lucite containers; anterior-body shielding for all males, headshielding for most females) (1 roentgen, R, = 2.6 X 10-4 coulomb/kg). Males were mated immediately after irradiation, and offspring conceived in both the presterile and poststerile periods (derived from postspermatogonial and spermatogonial stages, respectively) were examined in separate groups. The bulk of these offspring (6914 of 7793) came from irradiations with 600 R; the remainder from irradiations with 300, 400, 500, or 600 + 400 R (24 hr interval). Weighted average doses are shown in Table 1 which deletion mutants were simulated-see next paragraph.) Where an exceptional result was obtained with the two-animal sample, the blood from each animal was then retested separately. All other blood analyses were performed on single-animal samples, some requiring repeated bleeding. Exceptional animals were mated in appropriate crosses for genetic follow-up, and their offspring were individually analyzed for the same blood characters.
Electrophoresis of Hemoglobin and Serum Albumin. Blood was lysed, mixed with iodoacetic acid and ferricyanide, and electrophoresed on starch gels (11) . The hemoglobins of strains SEC (Hbbs/Hbbs) and 101 (Hbbd/Hbbd) are distinguishable on the basis of the amino acid present at position ,B13: glycine in strain SEC, and cysteine in strain 101. Iodoacetic acid adds to the cysteine to form a carboxymethyl derivative, which imparts an extra charge (Fig. 1) . It is clear that any mutant with an altered net charge of hemoglobin would have been detected. A deletion mutant was simulated by mixing equal parts of F1 (Hbbs/Hbbd) and either 101 or SEC bloods (Fig. 1A) . In these mixtures, one or the other of the normal F1 bands was clearly reduced.
Serum albumin was detected on the same gels by staining for Table 2 . Hemoglobin variants The hemoglobins of all of the exceptional F1 animals discovered had both an abnormal electrophoretic pattern and abnormal phosphate solubility and crystal structure. Of the five variants detected, four exhibited a diminished fast band (Fig. 1B) , and one a diminished slow band (Fig. 1C) hemoglobins of 872 and 6352 indicated that the genetic contribution from the irradiated SEC parent was not being expressed with regard to the a chain. The evidence for this is as follows. Position a68 of the aT-9 peptide is occupied by asparagine in 101 mice, and by serine and threonine in the two kinds of a chain of SEC mice. Analysis of aT-9 showed that asparagine was the only amino acid at position 68 in hemoglobins from 872 and 6352. (Fig. IC) Proc. Natl. Acad. Sci. USA 73 (1976) 2845 9732 has two chromosomes 7 derived from her 101 parent, and no chromosome 7 derived from her SEC parent. With regard to chromosomes 2, 4, 9, and 11 (and probably all the rest), she is a normal F1 animal. Double nondisjunction of a chromosome, which would explain the origin of 9732, has earlier been invoked in several cases involving chromosome 9 (13).
Serum albumin
Of the 8621 F1 mice tested by electrophoresis, none revealed a detectable alteration in mobility of serum albumin, nor a quantitative alteration in the stained band on the starch gel, as judged visually.
Other blood characters Four animals were observed to be anemic on the original test and subsequent retest, but showed no abnormality in hemoglobin characters ( Table 2 ). In addition, external observation of the F1 led to the discovery of two dominants, one at Ca (caracul) and one at an undetermined locus. A possible third miscellaneous variant could not be further tested since it was sterile. No cytology was done on this animal, which may have carried a chromosome aberration.
DISCUSSION
The major advantage of including the hemoglobin loci in mutagenesis experiments lies in the detailed knowledge, already available, about the normal product of these genes and therefore the relative ease with which alterations in the product can be characterized. It is hoped that such characterization will allow conclusions to be drawn about the nature of mutations induced by various mutagens. Several laboratories are also embarking on studies of mutation rates for biochemical variants, which include the hemoglobin loci. The results of the present experiment, in which two different major chromosome aberrations (duplication and double nondisjunction) mimicked hemoglobin mutations, illustrate the need for caution in interpreting F1 findings unless these are followed by thorough cytogenetic studies.
The tandem duplication is, to our knowledge, the first found in the mouse. The genetic imbalance caused by such duplications would ordinarily not be detectable in specific-locus experiments, where wild-type chromosomes are treated with mutagens. The new tandem duplication is of fundamental interest because of the information it will supply with regard to (a) correlations of the cytological and genetic maps, and (b) gene dosage effects in a chromosomal region for which many deficiencies and several X-autosome translocations are already available from earlier work.
The other three hemoglobin mutants resemble each other in nonexpression of the a chain. It is not yet known whether this nonexpression is the result of a small deficiency in chromosome 11, or whether it represents a fault in transcription or translation. The characteristics of the ultimate defect caused by these three mutations make it likely that they will provide extremely valuable animal models for human a thalassemia.
No cases of base-pair substitution were detected in the present series. However, it should be noted that only one of the mutants was derived from the irradiation of spermatogonia, the cell stage that yields the lowest frequency of chromosomal aberrations. Expansion of the experimental series should provide more critical information in the future.
The numbers of induced mutations so far observed, from irradiated spermatogonia and postspermatogonial stages, at the Hba and Hbb loci are too small for reliable estimates of mutation rates. However, it is worth noting that, as they stand, the rates are not out of line with those obtained in past experiments with other loci. For spermatogonia, the rate, based on one mutation in 6918 offspring and a weighted mean dose of 583 R, is 1.2 X 10-7/R per locus, with 90% confidence limits of (0.1 and 5.6) X 10-7. For postspermatogonial stages, the rate, based on the two observed mutations (excluding the presumed double nondisjunction) in 875 offspring for a weighted mean dose of 585 R, is 19.5 [90% confidence limits of (5.2 and 58.4) X 10-7/R per locus]. The two rates are approximately one-half and three times the mean rates obtained earlier at seven specific loci (a, b, c, p, d, se, s), for spermatogonia and postspermatogonial stages, respectively (1, 14) . The differences, even from the mean values for the seven loci, are clearly not statistically significant, and there is, of course, a considerable range of variation in mutation rates among the seven loci themselves. (The limited mutational information on five of these seven loci in the current experiment is not at variance with the results from the earlier work.)
